Workshop on primary progressive multiple sclerosis: meeting summary

Mult Scler. 2002 Apr;8(2):177-8. doi: 10.1191/1352458502ms792xx.
No abstract available

Publication types

  • Congress

MeSH terms

  • Adult
  • Clinical Trials as Topic
  • Cohort Studies
  • Diagnostic Imaging
  • Europe / epidemiology
  • Female
  • Genetic Predisposition to Disease
  • Glatiramer Acetate
  • Humans
  • Interferon beta-1a
  • Interferon beta-1b
  • Interferon-beta / therapeutic use
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Multiple Sclerosis, Chronic Progressive* / epidemiology
  • Multiple Sclerosis, Chronic Progressive* / genetics
  • Multiple Sclerosis, Chronic Progressive* / immunology
  • Multiple Sclerosis, Chronic Progressive* / pathology
  • Multiple Sclerosis, Chronic Progressive* / therapy
  • Oligodendroglia / pathology
  • Peptides / therapeutic use
  • Prospective Studies
  • Retrospective Studies
  • Riluzole / therapeutic use

Substances

  • Peptides
  • Interferon beta-1b
  • Glatiramer Acetate
  • Interferon-beta
  • Riluzole
  • Interferon beta-1a